1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Equipment & Services
Envista Holdings Corp

Envista Holdings Corp

NVST
Envista Holdings CorpUS flagNew York Stock Exchange
22.40
USD
-0.54
- -
3.65BMarket Cap
Envista Holdings Corp
NVST
(New York Stock Exchange)

Recent

price

22.40

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
18.02
18.18
18.4
16.78
12.09
15.56
15.77
15.38
14.58
16.19
16.93
Revenue per Share
1.76
1.95
1.49
1.6
0.21
2.11
1.49
-0.6
-6.5
0.28
0.41
Basic EPS, GAAP
2.38
2.01
2.12
2.35
1.48
1.9
0.66
1.3
1.76
1.37
1.33
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
0.7
0.8
2.91
4.5
3.79
-2.82
-2.61
-2.41
Book Value per Share
- -
0.7
0.72
-7.7
-4
-0.75
-2.31
-0.43
0.13
0.72
0.52
Tangible Book Value per Share
155
155
155
136
160
161
163
167
172
168
166
Basic Weighted Avg Shares
2,785
2,811
2,844
2,285
1,929
2,509
2,569
2,566
2,511
2,720
2,808
Sales/Revenue/Turnover
14.46
13.75
10.49
10.32
2.25
12.2
13.36
12.27
5.46
8.67
9.37
Operating Margin (%)
127
121
130
168
163
152
162
163
154
151
153
Depreciation Expense
272
301
231
218
33
340
243
-100
-1,119
47
68
Net Income, GAAP
32.29
22.14
23.38
21.22
- -
- -
16.17
- -
- -
73.48
66.22
Effective Tax Rate (%)
9.77
10.71
8.11
9.52
1.73
13.57
9.46
-3.9
-44.56
1.73
2.41
Profit Margin (%)
- -
166
146
293
-94
628
188
963
910
1,174
1,132
Working Capital
- -
- -
- -
1,507
1,060
1,004
992
1,508
1,397
1,559
1,550
LT Debt
- -
4,995
4,826
3,543
3,721
4,058
4,207
4,174
2,935
3,106
3,080
Total Equity
- -
12.04
4.66
3.75
- -
- -
5.09
- -
- -
1.35
1.9
Return on Invested Capital (%)
- -
14,687.8
6,235.14
26.9
- -
- -
13.14
- -
- -
5.11
6.96
Return on Capital (%)
- -
- -
- -
459.56
29.91
114.17
40.47
-14.67
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
39
39
39
LT Borrowings
1,445
1,448
1,439
LT Finance Leases
118
110
111
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
165
164
163
Market Capitalization
3,463
3,647
4,208

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
1,948
2,027
1,919
Cash, Cash Equivalents & STI
1,134
1,212
1,083
Accounts Receivable, Net
406
430
437
Inventories
291
288
300
Total Current Liabilities
822
853
787
Payables & Accruals
250
252
238
ST Debt
39
39
39
Deferred Revenue
177
185
188

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-2.38%
5.84%
Free Cash Flow
- -
16.67%
-23.89%
Net Income, GAAP
- -
332.97%
-104.2%
Sales/Revenue/Turnover
- -
7.7%
8.32%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
624
633
601
653
2,511
2025
617
682
670
751
2,720
2026
706
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.14
-6.69
0.05
0.01
-6.5
2025
0.1
0.16
-0.18
0.2
0.28
2026
0.24
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
DENTSPLY SIRONA Inc. (DY2.DE)
Meridian Bioscience, Inc. (0K0K.L)
Surgical Care Affiliates, Inc. (SCAI)
Hi-Clearance Inc. (1788.TWO)
Kindly MD, Inc. (KDLY)
Humasis Co. Ltd. (205470.KQ)
Business
Envista Holdings Corp (NYSE: NVST) develops and manufactures a broad portfolio of dental products and technologies for dental professionals worldwide. The company operates through two primary segments: Specialty Products & Technologies, which offers dental implant systems, prosthetics, clear aligners, brackets and wires, orthodontic and laboratory products; and Equipment & Consumables, which provides digital imaging systems, dental practice equipment, endodontic systems, restorative and impression materials, bonding agents and cements, and infection prevention products. Envista serves dental offices, orthodontists, oral surgeons, and laboratories with innovative solutions supporting integrated digital workflows, training programs, and comprehensive patient care tools across more than 120 countries. Founded in 2019 as a spin-off from Danaher Corp and headquartered in Brea, California, the company encompasses over 30 trusted brands with more than 125 years of combined industry heritage. In June 2025, Envista acquired Alpha-Bio France to strengthen its implant and prosthetics offerings in Europe; the company continues strategic mergers and acquisitions to expand its global reach and technological capabilities, anchored by the Envista Business System for operational excellence.

Company News

APIChat

  • zacks.com

    NVST Stock Explained for 2026 Growth Drivers and Risks

  • zacks.com

    Here's Why Envista (NVST) is a Strong Value Stock

  • gurufocus.com

    Envista Holdings Corp (NVST) Shares Surge 3.1% -- What GF Score of 82 Tells Investors

  • zacks.com

    Why Envista (NVST) is a Top Value Stock for the Long-Term

  • 247wallst.com

    Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win

  • marketbeat.com

    Envista Q1 Earnings Call Highlights

  • zacks.com

    Envista (NVST) International Revenue Performance Explored

  • zacks.com

    Why Envista (NVST) is a Top Growth Stock for the Long-Term

  • seekingalpha.com

    Envista: Spotlight On Q1 Outperformance And New Growth Drivers

  • seekingalpha.com

    Envista Holdings Corporation (NVST) Q1 2026 Earnings Call Transcript

  • zacks.com

    Here's What Key Metrics Tell Us About Envista (NVST) Q1 Earnings

  • zacks.com

    Envista (NVST) Surpasses Q1 Earnings and Revenue Estimates

  • prnewswire.com

    Envista Reports First Quarter 2026 Results

  • defenseworld.net

    Financial Survey: Stagezero Life Sciences (OTCMKTS:SZLSF) and Envista (NYSE:NVST)

  • defenseworld.net

    Envista Holdings Corporation $NVST Shares Purchased by Cwm LLC

  • prnewswire.com

    Envista Schedules First Quarter 2026 Earnings Call

  • zacks.com

    Here's Why Envista (NVST) is a Strong Value Stock

  • zacks.com

    Here's Why You Should Add NVST Stock to Your Portfolio Right Now

  • zacks.com

    Envista Stock Up 42.5% in a Year: What's Driving It?

  • zacks.com

    NVST or SYK: Which Is the Better Value Stock Right Now?